USE OF AN ANTI-GM-CSF ANTAGONIST AND AN ANTI-CCR2 ANTAGONIST IN THE TREATMENT OF AN INFECTIOUS DISEASE
The present invention relates to combinations comprising anti-GM-CSF antagonists and anti- CCR2 antagonists in the treatment and prevention of infections caused by agents inducing hemorrhagic fever or in the modulation of an individual's immune or cellular response that has been exposed to, is...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZALEVSKY, JONATHAN SOUBERBIELLE, BERNARD |
| description | The present invention relates to combinations comprising anti-GM-CSF antagonists and anti- CCR2 antagonists in the treatment and prevention of infections caused by agents inducing hemorrhagic fever or in the modulation of an individual's immune or cellular response that has been exposed to, is infected or suspected to be infected with such agents, e.g., Ebola viruses.
L'invention concerne des combinaisons comprenant des antagonistes anti-GM-CSF et des antagonistes anti-CCR2 pour traiter et prévenir des infections provoquées par des agents induisant une fièvre hémorragique ou pour moduler la réponse cellulaire ou immunitaire d'un individu qui a été exposé, infecté ou susceptible d'être infecté par de tels agents, par exemple, le virus Ebola. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2016079276A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2016079276A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2016079276A13</originalsourceid><addsrcrecordid>eNrjZEgLDXZV8HdTcPQDohBPXXdfXedgEDfE0d3fzzM4BMh0gcs6OwcZIct5-imEeLgqhAS5Oob4uvqFQE3y9HNzdQ7x9A8NVnDxDHZ1DHblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoZmBuaWRuZmjobGxKkCAACaNTA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF AN ANTI-GM-CSF ANTAGONIST AND AN ANTI-CCR2 ANTAGONIST IN THE TREATMENT OF AN INFECTIOUS DISEASE</title><source>esp@cenet</source><creator>ZALEVSKY, JONATHAN ; SOUBERBIELLE, BERNARD</creator><creatorcontrib>ZALEVSKY, JONATHAN ; SOUBERBIELLE, BERNARD</creatorcontrib><description>The present invention relates to combinations comprising anti-GM-CSF antagonists and anti- CCR2 antagonists in the treatment and prevention of infections caused by agents inducing hemorrhagic fever or in the modulation of an individual's immune or cellular response that has been exposed to, is infected or suspected to be infected with such agents, e.g., Ebola viruses.
L'invention concerne des combinaisons comprenant des antagonistes anti-GM-CSF et des antagonistes anti-CCR2 pour traiter et prévenir des infections provoquées par des agents induisant une fièvre hémorragique ou pour moduler la réponse cellulaire ou immunitaire d'un individu qui a été exposé, infecté ou susceptible d'être infecté par de tels agents, par exemple, le virus Ebola.</description><language>eng ; fre</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2016</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160526&DB=EPODOC&CC=WO&NR=2016079276A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76516</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160526&DB=EPODOC&CC=WO&NR=2016079276A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZALEVSKY, JONATHAN</creatorcontrib><creatorcontrib>SOUBERBIELLE, BERNARD</creatorcontrib><title>USE OF AN ANTI-GM-CSF ANTAGONIST AND AN ANTI-CCR2 ANTAGONIST IN THE TREATMENT OF AN INFECTIOUS DISEASE</title><description>The present invention relates to combinations comprising anti-GM-CSF antagonists and anti- CCR2 antagonists in the treatment and prevention of infections caused by agents inducing hemorrhagic fever or in the modulation of an individual's immune or cellular response that has been exposed to, is infected or suspected to be infected with such agents, e.g., Ebola viruses.
L'invention concerne des combinaisons comprenant des antagonistes anti-GM-CSF et des antagonistes anti-CCR2 pour traiter et prévenir des infections provoquées par des agents induisant une fièvre hémorragique ou pour moduler la réponse cellulaire ou immunitaire d'un individu qui a été exposé, infecté ou susceptible d'être infecté par de tels agents, par exemple, le virus Ebola.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2016</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZEgLDXZV8HdTcPQDohBPXXdfXedgEDfE0d3fzzM4BMh0gcs6OwcZIct5-imEeLgqhAS5Oob4uvqFQE3y9HNzdQ7x9A8NVnDxDHZ1DHblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoZmBuaWRuZmjobGxKkCAACaNTA</recordid><startdate>20160526</startdate><enddate>20160526</enddate><creator>ZALEVSKY, JONATHAN</creator><creator>SOUBERBIELLE, BERNARD</creator><scope>EVB</scope></search><sort><creationdate>20160526</creationdate><title>USE OF AN ANTI-GM-CSF ANTAGONIST AND AN ANTI-CCR2 ANTAGONIST IN THE TREATMENT OF AN INFECTIOUS DISEASE</title><author>ZALEVSKY, JONATHAN ; SOUBERBIELLE, BERNARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2016079276A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2016</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZALEVSKY, JONATHAN</creatorcontrib><creatorcontrib>SOUBERBIELLE, BERNARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZALEVSKY, JONATHAN</au><au>SOUBERBIELLE, BERNARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF AN ANTI-GM-CSF ANTAGONIST AND AN ANTI-CCR2 ANTAGONIST IN THE TREATMENT OF AN INFECTIOUS DISEASE</title><date>2016-05-26</date><risdate>2016</risdate><abstract>The present invention relates to combinations comprising anti-GM-CSF antagonists and anti- CCR2 antagonists in the treatment and prevention of infections caused by agents inducing hemorrhagic fever or in the modulation of an individual's immune or cellular response that has been exposed to, is infected or suspected to be infected with such agents, e.g., Ebola viruses.
L'invention concerne des combinaisons comprenant des antagonistes anti-GM-CSF et des antagonistes anti-CCR2 pour traiter et prévenir des infections provoquées par des agents induisant une fièvre hémorragique ou pour moduler la réponse cellulaire ou immunitaire d'un individu qui a été exposé, infecté ou susceptible d'être infecté par de tels agents, par exemple, le virus Ebola.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2016079276A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | USE OF AN ANTI-GM-CSF ANTAGONIST AND AN ANTI-CCR2 ANTAGONIST IN THE TREATMENT OF AN INFECTIOUS DISEASE |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T14%3A45%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZALEVSKY,%20JONATHAN&rft.date=2016-05-26&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2016079276A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |